← All trials
NCT05452889
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2023
- Primary completion
- Jun 30, 2024
- Completion date
- Dec 31, 2025
- First posted
- Jul 11, 2022
- Last posted
- Dec 5, 2022
- Enrollment
- 50
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of PittsburghLead sponsor
- BayerCollaborator
- National Heart, Lung, and Blood Institute (NHLBI)Collaborator
- University of PittsburghOverall official - principal investigator
- University of PittsburghSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.